Lemieux Foundation, UPMC join forces on $5 million lymphoma center

Share with others:


Print Email Read Later

The Mario Lemieux Foundation and UPMC are partnering on a new $5 million center dedicated to rare and hard-to-treat cases of childhood lymphoma.

The Mario Lemieux Lymphoma Center for Children and Young Adults, funded by $2.5 million from the Lemieux Foundation and matching funds from UPMC, will be housed at Children’s Hospital of UPMC in Lawrenceville and led by Linda McAllister-Lucas, chief of the Division of Pediatric Hematology/Oncology.

“I was fortunate to have a type of lymphoma that has proven treatments with good outcomes,” said Mr. Lemieux, referencing his 1993 diagnosis of Hodgkin’s disease. “I want to create a place of hope for kids and young adults and their families who are diagnosed with lymphomas that have no known cures.”

The center will focus on clinical care, as well as laboratory and clinical research. It will begin operations immediately out of existing space at Children’s Hospital.

“The support of the Lemieux Foundation gives us the ability to enhance our basic and clinical research in a way that could lead to improved and potentially new treatments for patients around the world who currently have very limited options,” said Dr. McAllister-Lucas.


Anya Sostek: asostek@post-gazette.com or 412-263-1308.

Join the conversation:

Commenting policy | How to report abuse
To report inappropriate comments, abuse and/or repeat offenders, please send an email to socialmedia@post-gazette.com and include a link to the article and a copy of the comment. Your report will be reviewed in a timely manner. Thank you.
Commenting policy | How to report abuse

Advertisement
Advertisement
Advertisement

You have 2 remaining free articles this month

Try unlimited digital access

If you are an existing subscriber,
link your account for free access. Start here

You’ve reached the limit of free articles this month.

To continue unlimited reading

If you are an existing subscriber,
link your account for free access. Start here